These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 26044557)

  • 61. C9orf72 is required for proper macrophage and microglial function in mice.
    O'Rourke JG; Bogdanik L; Yáñez A; Lall D; Wolf AJ; Muhammad AK; Ho R; Carmona S; Vit JP; Zarrow J; Kim KJ; Bell S; Harms MB; Miller TM; Dangler CA; Underhill DM; Goodridge HS; Lutz CM; Baloh RH
    Science; 2016 Mar; 351(6279):1324-9. PubMed ID: 26989253
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing.
    Schludi MH; May S; Grässer FA; Rentzsch K; Kremmer E; Küpper C; Klopstock T; ; ; Arzberger T; Edbauer D
    Acta Neuropathol; 2015 Oct; 130(4):537-55. PubMed ID: 26085200
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport.
    Zhang K; Donnelly CJ; Haeusler AR; Grima JC; Machamer JB; Steinwald P; Daley EL; Miller SJ; Cunningham KM; Vidensky S; Gupta S; Thomas MA; Hong I; Chiu SL; Huganir RL; Ostrow LW; Matunis MJ; Wang J; Sattler R; Lloyd TE; Rothstein JD
    Nature; 2015 Sep; 525(7567):56-61. PubMed ID: 26308891
    [TBL] [Abstract][Full Text] [Related]  

  • 64. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport.
    Freibaum BD; Lu Y; Lopez-Gonzalez R; Kim NC; Almeida S; Lee KH; Badders N; Valentine M; Miller BL; Wong PC; Petrucelli L; Kim HJ; Gao FB; Taylor JP
    Nature; 2015 Sep; 525(7567):129-33. PubMed ID: 26308899
    [TBL] [Abstract][Full Text] [Related]  

  • 65. C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD.
    O'Rourke JG; Bogdanik L; Muhammad AKMG; Gendron TF; Kim KJ; Austin A; Cady J; Liu EY; Zarrow J; Grant S; Ho R; Bell S; Carmona S; Simpkinson M; Lall D; Wu K; Daughrity L; Dickson DW; Harms MB; Petrucelli L; Lee EB; Lutz CM; Baloh RH
    Neuron; 2015 Dec; 88(5):892-901. PubMed ID: 26637796
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration.
    Gomez-Deza J; Lee YB; Troakes C; Nolan M; Al-Sarraj S; Gallo JM; Shaw CE
    Acta Neuropathol Commun; 2015 Jun; 3():38. PubMed ID: 26108573
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Isoform-specific antibodies reveal distinct subcellular localizations of C9orf72 in amyotrophic lateral sclerosis.
    Xiao S; MacNair L; McGoldrick P; McKeever PM; McLean JR; Zhang M; Keith J; Zinman L; Rogaeva E; Robertson J
    Ann Neurol; 2015 Oct; 78(4):568-83. PubMed ID: 26174152
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS.
    Prudencio M; Belzil VV; Batra R; Ross CA; Gendron TF; Pregent LJ; Murray ME; Overstreet KK; Piazza-Johnston AE; Desaro P; Bieniek KF; DeTure M; Lee WC; Biendarra SM; Davis MD; Baker MC; Perkerson RB; van Blitterswijk M; Stetler CT; Rademakers R; Link CD; Dickson DW; Boylan KB; Li H; Petrucelli L
    Nat Neurosci; 2015 Aug; 18(8):1175-82. PubMed ID: 26192745
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice.
    Peters OM; Cabrera GT; Tran H; Gendron TF; McKeon JE; Metterville J; Weiss A; Wightman N; Salameh J; Kim J; Sun H; Boylan KB; Dickson D; Kennedy Z; Lin Z; Zhang YJ; Daughrity L; Jung C; Gao FB; Sapp PC; Horvitz HR; Bosco DA; Brown SP; de Jong P; Petrucelli L; Mueller C; Brown RH
    Neuron; 2015 Dec; 88(5):902-909. PubMed ID: 26637797
    [TBL] [Abstract][Full Text] [Related]  

  • 70. C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS/FTD.
    Liu Y; Pattamatta A; Zu T; Reid T; Bardhi O; Borchelt DR; Yachnis AT; Ranum LP
    Neuron; 2016 May; 90(3):521-34. PubMed ID: 27112499
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS.
    Jovičić A; Mertens J; Boeynaems S; Bogaert E; Chai N; Yamada SB; Paul JW; Sun S; Herdy JR; Bieri G; Kramer NJ; Gage FH; Van Den Bosch L; Robberecht W; Gitler AD
    Nat Neurosci; 2015 Sep; 18(9):1226-9. PubMed ID: 26308983
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death.
    Sellier C; Campanari ML; Julie Corbier C; Gaucherot A; Kolb-Cheynel I; Oulad-Abdelghani M; Ruffenach F; Page A; Ciura S; Kabashi E; Charlet-Berguerand N
    EMBO J; 2016 Jun; 35(12):1276-97. PubMed ID: 27103069
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs.
    Jiang J; Zhu Q; Gendron TF; Saberi S; McAlonis-Downes M; Seelman A; Stauffer JE; Jafar-Nejad P; Drenner K; Schulte D; Chun S; Sun S; Ling SC; Myers B; Engelhardt J; Katz M; Baughn M; Platoshyn O; Marsala M; Watt A; Heyser CJ; Ard MC; De Muynck L; Daughrity LM; Swing DA; Tessarollo L; Jung CJ; Delpoux A; Utzschneider DT; Hedrick SM; de Jong PJ; Edbauer D; Van Damme P; Petrucelli L; Shaw CE; Bennett CF; Da Cruz S; Ravits J; Rigo F; Cleveland DW; Lagier-Tourenne C
    Neuron; 2016 May; 90(3):535-50. PubMed ID: 27112497
    [TBL] [Abstract][Full Text] [Related]  

  • 74. C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice.
    Atanasio A; Decman V; White D; Ramos M; Ikiz B; Lee HC; Siao CJ; Brydges S; LaRosa E; Bai Y; Fury W; Burfeind P; Zamfirova R; Warshaw G; Orengo J; Oyejide A; Fralish M; Auerbach W; Poueymirou W; Freudenberg J; Gong G; Zambrowicz B; Valenzuela D; Yancopoulos G; Murphy A; Thurston G; Lai KM
    Sci Rep; 2016 Mar; 6():23204. PubMed ID: 26979938
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bromodomain inhibitors regulate the C9ORF72 locus in ALS.
    Zeier Z; Esanov R; Belle KC; Volmar CH; Johnstone AL; Halley P; DeRosa BA; Khoury N; van Blitterswijk M; Rademakers R; Albert J; Brothers SP; Wuu J; Dykxhoorn DM; Benatar M; Wahlestedt C
    Exp Neurol; 2015 Sep; 271():241-50. PubMed ID: 26099177
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The function of RNA-binding proteins at the synapse: implications for neurodegeneration.
    Sephton CF; Yu G
    Cell Mol Life Sci; 2015 Oct; 72(19):3621-35. PubMed ID: 26047658
    [TBL] [Abstract][Full Text] [Related]  

  • 77. C9ORF72 expression and cellular localization over mouse development.
    Atkinson RA; Fernandez-Martos CM; Atkin JD; Vickers JC; King AE
    Acta Neuropathol Commun; 2015 Sep; 3():59. PubMed ID: 26408000
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Differential Toxicity of Nuclear RNA Foci versus Dipeptide Repeat Proteins in a Drosophila Model of C9ORF72 FTD/ALS.
    Tran H; Almeida S; Moore J; Gendron TF; Chalasani U; Lu Y; Du X; Nickerson JA; Petrucelli L; Weng Z; Gao FB
    Neuron; 2015 Sep; 87(6):1207-1214. PubMed ID: 26402604
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.